Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

P P Munksgaard, Francisco Mansilla, A-S Brems Eskildsen, Niels Fristrup, Karin Birkenkamp-Demtröder, Benedicte Parm Ulhøi, Michael Skov Borre, M Agerbæk, G G Hermann, T F Orntoft, L Dyrskjøt

    41 Citationer (Scopus)

    Abstract

    Markers for outcome prediction in bladder cancer are urgently needed. We have previously identified a molecular signature for predicting progression in non-muscle-invasive bladder cancer. ANXA10 was one of the markers included in the signature and we now validated the prognostic relevance of ANXA10 at the protein level.
    OriginalsprogEngelsk
    TidsskriftB J C
    Vol/bind105
    Udgave nummer9
    Sider (fra-til)1379-87
    Antal sider9
    ISSN0007-0920
    DOI
    StatusUdgivet - 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Low ANXA10 expression is associated with disease aggressiveness in bladder cancer'. Sammen danner de et unikt fingeraftryk.

    Citationsformater